N-[(3,4-Dichlorophenyl)methyl]-6,7,8-trimethoxy-4-quinazolinamine

Catalog No. :
ACABHM812
CAS No. :
150450-15-0
Molecular Formula :
C18H17Cl2N3O3
Molecular Weight :
394.26

IUPAC Name:N-(3,4-dichlorobenzyl)-6,7,8-trimethoxyquinazolin-4-amine

N-[(3,4-Dichlorophenyl)methyl]-6,7,8-trimethoxy-4-quinazolinamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$744.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(3,4-Dichlorophenyl)methyl]-6,7,8-trimethoxy-4-quinazolinamine
IUPAC NameN-(3,4-dichlorobenzyl)-6,7,8-trimethoxyquinazolin-4-amine
Molecular FormulaC18H17Cl2N3O3
Molecular Weight394.26
SMILESCOC1=C(OC)C(OC)=CC2=C(NCC3=CC=C(Cl)C(Cl)=C3)N=CN=C12
InChI KeyIUGNCPJMMRXPHR-UHFFFAOYSA-N
SynonymN-[(3,4-DICHLOROPHENYL)METHYL]-6,7,8-TRIMETHOXY-4-QUINAZOLINAMINE;N-[(3,4-dichlorophenyl)methyl]-6,7,8-trimethoxyquinazolin-4-amine;4-Quinazolinamine, N-[(3,4-dichlorophenyl)methyl]-6,7,8-trimethoxy-;n-(3,4-dichlorobenzyl)-6,7,8-trimethoxyquinazolin-4-amine
CAS No.150450-15-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACABHM812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACABHM812 route product structure diagram
    ACABHM812150450-15-0
Inquiry

2. ACABHM812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACABHM812 route product structure diagram
    ACABHM812150450-15-0
Inquiry

Comments (0)